Cordis is a worldwide leader in the development and manufacturing of interventional vascular technology, offering a rich legacy of innovation in high-quality, minimally invasive cardiovascular products. For over 60 years, Cordis has been dedicated to advancing patient care by providing physicians with the tools they need to treat complex vascular conditions. The company focuses on cardiology and endovascular solutions, striving to improve the lives of patients globally through pioneering medical devices and a commitment to clinical excellence.
Serves as the central hub for global operations, corporate leadership, strategic planning, research and development oversight, and administrative functions.
Modern facility designed to foster collaboration and innovation, likely including advanced research labs and training centers for medical professionals.
A dynamic and patient-focused work environment, emphasizing innovation, collaboration, quality, and a commitment to improving healthcare outcomes.
The Miami Lakes location positions Cordis within a thriving medical technology and life sciences ecosystem in South Florida, facilitating access to talent, research institutions, and industry partners. It marks Cordis's re-emergence as an independent company focused on cardiovascular innovation.
Cordis supports healthcare professionals and patients worldwide through a comprehensive global network. This includes strategically located manufacturing facilities ensuring product supply, dedicated research and development centers driving innovation, and extensive commercial operations (sales, marketing, distribution, and clinical support) across the Americas, Europe, Middle East, Africa, and Asia-Pacific regions. This allows Cordis to effectively serve diverse markets and address local healthcare needs with its interventional vascular technologies.
14201 N.W. 60th Avenue
Miami Lakes
Florida
USA
Address: Cordis APAC, 38 Beach Road, #29-11 South Beach Tower, Singapore 189767
To drive growth and market penetration in key APAC countries, tailor strategies to local healthcare needs, and manage distribution networks and partnerships within the Asia-Pacific region.
Address: Cordis Medizintechnik GmbH, Oststraße 12, 22844 Norderstedt, Germany
To manage and expand Cordis's presence in the EMEA market, ensuring regulatory compliance, and providing localized support to healthcare providers and patients in the region.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Cordis' leadership includes:
Cordis has been backed by several prominent investors over the years, including:
Cordis has recently strengthened its executive leadership, particularly in its financial division, with key appointments. Publicly available information on executive exits within the last 12 months is limited.
Discover the tools Cordis uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Cordis likely utilizes standard corporate email address formats. Common patterns include combining the employee's first name and last name, or first initial and last name, with the @cordis.com domain. For example, 'firstname.lastname@cordis.com' or 'flastname@cordis.com'.
firstname.lastname@cordis.com
Format
jane.doe@cordis.com
Example
85%
Success rate
Cordis Press Release • May 9, 2024
Cordis announced the appointment of Chris Barry as its new Chief Financial Officer. Barry brings over 20 years of financial leadership experience, primarily in the medical device and healthcare sectors, to steer Cordis's financial strategy and operations....more
Cordis Press Release • October 24, 2023
Cordis presented new clinical data and showcased its latest interventional cardiology innovations at the Transcatheter Cardiovascular Therapeutics (TCT) 2023 conference, reinforcing its commitment to advancing cardiovascular care....more
Cordis Press Release • August 2, 2023
Cordis announced the enrollment of the first patient in its innovative Seldinger-guided Puncture and Radial Artery Device Investigative Study (RADIANCE II) to evaluate the S.M.A.R.T. RADIANZ™ Vascular Stent System, designed for treating lesions in the radial artery....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Cordis, are just a search away.